Ampio Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.51-5.68-2.52-5.101.27-9.49-16.65-9.09-0.40-0.19-0.13-0.13
Price/Sales ratio
2.24K156.53N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
2.604.917.28-7.758.2412.8015.694.160.290.490.2712.80
Price/Cash Flow ratio
-5.60-6.88-3.30-23.22-3.55-5.36-18.65-8.06-0.16-0.19-0.09-3.55
Price/Free Cash Flow ratio
-4.37-6.82-3.30-23.07-3.39-5.35-18.57-8.00-0.16-0.19-0.09-3.39
Price/Earnings Growth ratio
-0.210.300.05-0.04-0.000.07-0.290.260.010.03-0.00-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-2818.46%68.23%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-50882.57%-2864.79%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-50853.57%-2900.24%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-49650.87%-2753.65%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
2.36%3.83%-5.41%-70.00%132.90%36.28%-3.80%26.88%48.17%N/AN/A36.28%
Return on Assets
-54.25%-63.48%-140.95%-338.83%242.23%-62.02%-72.11%-32.15%-62.31%-150.48%-176.94%-62.02%
Return On Equity
-57.66%-86.51%-288.85%151.83%649.07%-134.78%-94.20%-45.75%-71.82%-256.90%-141.45%-134.78%
Return on Capital Employed
-58.67%-74.16%-149.04%-136.10%-88.43%-241.27%-72.31%-74.64%-195.28%-283.27%-142.62%-241.27%
Liquidity Ratios
Current Ratio
13.925.292.532.175.771.9210.08N/AN/AN/A11.185.77
Quick Ratio
13.925.302.532.175.771.929.936.7211.182.4110.615.77
Cash ratio
13.674.882.292.115.471.529.456.6110.611.7210.615.47
Days of Sales Outstanding
N/A12.07N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A-38.00N/AN/AN/AN/A82.41397.36N/AN/AN/AN/A
Operating Cycle
N/A-25.92N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
537.322.84KN/A1.78K492.7143.3257.63142.4617.021.09KN/A43.32
Cash Conversion Cycle
-537.32-2.87KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.10N/AN/A0.040.040.130.10
Debt Equity Ratio
N/AN/AN/AN/AN/A0.22N/AN/A0.050.080.150.22
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.15N/AN/A0.02N/A0.020.15
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.18N/AN/A0.040.070.040.18
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-153.73N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-10.47N/AN/A-34.41-31.25-52.14-10.47
Company Equity Multiplier
1.061.362.04-0.442.672.171.301.421.151.701.152.17
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-400.33-22.74N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.281.001.001.001.041.001.001.001111.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-10.47N/AN/A-34.41-31.25-52.14-10.47
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-59.39N/AN/A-62.14-31.25-94.17-59.39
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A